BioInnovation Institute has opened its first international base in London [...]

Verdiva Bio has reported new preclinical data for two obesity [...]

The Society for RNA Therapeutics (SRT) has expanded its leadership [...]

London-based technology company Apoha has emerged from stealth with $36 [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

Lithuania’s life sciences sector is preparing to showcase its rapid [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.